NCT05799469View on ClinicalTrials.gov

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

May 31, 2027

Study Completion Date

December 31, 2027

Conditions
Locally Advanced Cervical Cancer
Interventions
DRUG

Envafolimab

SC

DRUG

Cisplatin

IV infusion

RADIATION

External Beam Radiotherapy (EBRT)

45-50.4Gy

RADIATION

Brachytherapy (BT)

Performed according to clinically required dose

Trial Locations (1)

400000

Chongqing university Cancer Hospital, Chongqing

All Listed Sponsors
lead

Chongqing University Cancer Hospital

OTHER

NCT05799469 - Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer | Biotech Hunter | Biotech Hunter